শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

Brimonidine Tartrate

Drugs for miotics and glaucoma Prescription
Check interactions
🌐 View in English

ইঙ্গিত

Hypertension Glaucoma

Brimodin ophthalmic solution is used to lower eye pressure in people with open-angle glaucoma or ocular hypertension. It comes in a few strengths for different needs: the 0.2% solution helps lower elevated intraocular pressure, the 0.15% solution helps keep intraocular pressure under control in chronic open-angle glaucoma or ocular hypertension, and the 0.025% solution is used simply to ease eye redness caused by minor irritation.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Brimonidine is an α-2 adrenoreceptor agonist with greater selectivity for the α-2 receptor than the α-1 receptor. Applied topically, Brimonidine Tartrate eye drops lower intraocular pressure (IOP) in humans. When used as directed, Brimonidine Tartrate reduces elevated IOP while having minimal effect on cardiovascular parameters. The eye drops act quickly, with the peak IOP-lowering effect seen around two hours after dosing, and this effect lasts 12 hours or longer. Fluorophotometric studies in both animals and humans point to a dual mechanism of action: Brimonidine Tartrate eye drops lower IOP by reducing the production of aqueous humor and by improving uveoscleral outflow.

Pregnancy & Breastfeeding

Pregnancy: There is no adequate, well-controlled research on the use of this medicine in pregnant women. Animal studies have shown that Brimonidine crosses the placenta and reaches the fetal circulation to a limited extent. For this reason, Brimonidine Tartrate 0.2% eye drops should be used during pregnancy only if the expected benefit to the mother outweighs the possible risk to the unborn child.

Breastfeeding: It is not known whether this medicine passes into human breast milk, though animal studies have shown that Brimonidine Tartrate is excreted in breast milk. Because of this, a decision should be made either to stop breastfeeding or to stop the medicine, weighing how important the treatment is for the mother.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: 0.2% ophthalmic solution: The recommended dose is one drop of 0.2% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart. This ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.0.15% ophthalmic solution: The recommended dose is one drop of 0.15% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.0.025% ophthalmic solution: Instill 1 drop in the affected eye(s) every 6-8 hours. Do not use it more than 4 times daily. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →